* Flubendazolum [INN-Latin],

* (5-(4-Fluorobenzoyl)-1H-benzimidazole-2-yl)carbamic acid methyl ester,

* Methyl 5-(p-fluorobenzoyl)-2-benzimidazolecarbamate,

* Methyl N-(5-(p-fluorobenzoyl)-2-benzimidazolyl)carbamate,

* 2-Benzimidazolecarbamic acid, 5- (p-fluorobenzoyl)-, methyl ester,

* AIDS-084892, * AIDS084892,

* Carbamic acid, (5-(4-fluorobenzoyl)-1H-benzimidazol-2-yl)-, methyl ester,

* Carbamic acid, [5- (4-fluorobenzoyl)-1H-benzimidazol-2-yl]-, methyl ester,

* CCRIS 4480, * EINECS 250-624-4,

* Flubendazol [INN-Spanish],

* Flubendazole [USAN:BAN:INN],

* Flubenol, * Flumoxal, * Flumoxane, * Fluvermal,

* N-{5-[(4-Fluorophenyl)carbonyl]benzimidazol-2-yl}methyloxymethanamide,

* NSC 313680, *NSC313680,

Flubendazole is a synthetic anthelmintic belonging to the benzimidazole carbamates which acts by inhibiting the microtubular assembly in absorptive cells of nematodes. It acts by binding to tubulin, the dimeric subunit protein of the microtubules. It inhibits microtubular assembly in absorptive cells: i.e. of intestinal cells of nematodes. This is shown by disappearance of cytoplasmic microtubules, accumulation of secretory granules in the cytoplasm due to a block in their transport, leading to an impaired coating of the cellular membrane and a decreased digestion and absorption of nutrients. Irreversible lytic degeneration of the cell, due to the accumulation of secretory substances (hydrolytic and proteolytic enzymes), results in the death of the parasite.